These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2568688)

  • 21. [New non-benzodiazepine hypnotics. Progress in therapy of sleep disorders?].
    Hajak G; Rüther E
    Internist (Berl); 1995 Nov; 36(11):1085-90; discussion 1090-1. PubMed ID: 8543446
    [No Abstract]   [Full Text] [Related]  

  • 22. [Buspirone--a wide-spectrum preparation].
    Molodavkin GM; Voronina TA
    Eksp Klin Farmakol; 1997; 60(2):3-6. PubMed ID: 9206564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral pharmacology of zopiclone.
    Ueki S
    Sleep; 1987; 10 Suppl 1():1-6. PubMed ID: 2894069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA-benzodiazepine receptors.
    Wamsley JK
    Am J Psychiatry; 1992 Apr; 149(4):582-3. PubMed ID: 1348164
    [No Abstract]   [Full Text] [Related]  

  • 25. [Molecular mechanism of action of benzodiazepines].
    Quast U
    Fortschr Med; 1981 May; 99(20):788-94. PubMed ID: 6114911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological studies on zopiclone.
    Julou L; Bardone MC; Blanchard JC; Garret C; Stutzmann JM
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():46-58. PubMed ID: 6145682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models.
    Carling RW; Madin A; Guiblin A; Russell MG; Moore KW; Mitchinson A; Sohal B; Pike A; Cook SM; Ragan IC; McKernan RM; Quirk K; Ferris P; Marshall G; Thompson SA; Wafford KA; Dawson GR; Atack JR; Harrison T; Castro JL; Street LJ
    J Med Chem; 2005 Nov; 48(23):7089-92. PubMed ID: 16279764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone: chemistry, pharmacology, and behavior.
    Skolnick P; Paul SM
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):40-4. PubMed ID: 6130072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacology of anxiolytics and their therapeutic use].
    Tada K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
    [No Abstract]   [Full Text] [Related]  

  • 30. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations among measures of response to benzodiazepines in man.
    Bond A; Lader M
    Pharmacol Biochem Behav; 1983 Feb; 18(2):295-8. PubMed ID: 6132407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Zopiclone. Data of experimental pharmacology and clinical use].
    Stutzmann JM; Delahaye C; Allain H
    Therapie; 1993; 48(1):33-42. PubMed ID: 8356543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacology of cyclopyrrolone derivatives acting at the GABAA/benzodiazepine receptor.
    Doble A; Canton T; Piot O; Zundel JL; Stutzmann JM; Cotrel C; Blanchard JC
    Adv Biochem Psychopharmacol; 1992; 47():407-18. PubMed ID: 1324585
    [No Abstract]   [Full Text] [Related]  

  • 34. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
    McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The modulation of synaptic GABA(A) receptors in the thalamus by eszopiclone and zolpidem.
    Jia F; Goldstein PA; Harrison NL
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1000-6. PubMed ID: 19033556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What should be expected of an anxiolytic drug? (author's transl)].
    Gorceix A
    Nouv Presse Med; 1982 May; 11(22):1684-6. PubMed ID: 6124933
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates.
    Dixon CI; Rosahl TW; Stephens DN
    Pharmacol Biochem Behav; 2008 Jul; 90(1):1-8. PubMed ID: 18313124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.